FIELD: medicine.
SUBSTANCE: in course of experiment femoral artery is exposed with further installation of catheter-introducer, guide. Sclerosing preparation, namely amyl or isobutyl alcohol or mixture of said alcohol with ethyl alcohol in ratio 1:1 is introduced through injection X-ray-contrast microcatheter. Injection of sclerosing preparation is realised into predetermined section of hypertrophy to the depth not less than 1/2 of myocardium thickness in volume 0.3-0.4 ml. After that microcatheter with guide is removed and gradient of arterial pressure on heart valve in output part of ventricle is registered.
EFFECT: increased efficiency of ablation of hypertrophied section of myocardium, which can contribute to reduction of risk of development of disease recurrence in remote period.
3 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR CHEMICAL TISSUE ABLATION AND ITS APPLICATION | 2022 |
|
RU2791906C1 |
| METHOD FOR TREATING VENTRICULAR ARRHYTHMIAS (VARIANTS) | 2016 |
|
RU2651044C2 |
| METHOD FOR MODELING STABLE ATRIAL FIBRILLATION IN ANIMALS (VARIANTS) | 2021 |
|
RU2760087C1 |
| INTERVENTRICULAR SEPTUM VISUALISATION TECHNIQUE IN ALCOHOL SEPTAL ABLATION | 2008 |
|
RU2401068C2 |
| METHOD FOR MODELLING CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION IN LARGE ANIMALS | 2023 |
|
RU2811651C1 |
| METHOD OF SURGICAL TREATMENT OF PATIENTS WITH COMBINED ATHEROSCLEROTIC AFFECTION OF CAROTID AND CORONARY ARTERIES | 2010 |
|
RU2476165C2 |
| TRANSCATHETER THORACOSCOPIC METHOD FOR MITRAL VALVE REPLACEMENT IN PATIENTS WITH EXTREME RISK OF SURGICAL TREATMENT (OPTIONS) | 2017 |
|
RU2675068C1 |
| METHOD FOR MITRAL VALVE THORACOSCOPIC TRANSCATHETER REPROTHESIS BY SELF-DEPLOYING BIOLOGICAL PROTHESIS (VERSIONS) | 2016 |
|
RU2632540C1 |
| METHOD OF TRANSVENOUS TRANSSEPTAL ACCESS TO HEAD AND NECK ARTERIES | 2013 |
|
RU2526464C1 |
| METHOD OF SURGICAL TREATMENT OF OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN CHILDREN UNDER 5 YEARS OF AGE | 2023 |
|
RU2813761C1 |
